BirgitKnoechelMD

PubMed

• 1 citations
  Dual role of signaling pathways in myeloma requires cell type-specific targeting of ligand-receptor interactions.
  Pablo Hernandez-Lopez, Tushara Vijaykumar, Praveen Anand, Daniel Auclair, Julia Frede
  Blood Advances. 2024-06-25
• 32 citations
  Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering.
  Li Li, Vakul Mohanty, Jinzhuang Dou, Yuefan Huang, Pinaki P Banerjee
  Science Advances. 2023-07-28
• 5 citations
  Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy.
  Nam Gyu Im, Amy Guillaumet-Adkins, Megha Wal, Anna J Rogers, Julia Frede
  Cancer Immunology Research. 2022-09-01

Abstracts/Posters

• Circulating Tumor DNA in the Peripheral Blood As Early Predictor of Clinical Outcome in Relapsed/ Refractory Multiple Myeloma
  Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Chromatin Structure Dynamics Preserve Genome Stability in Multiple Myeloma
  Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Defining the Differentiation States of Multiple Myeloma at Single Cell Resolution Reveals Opportunities for Immunotherapy
  Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Single Cell RNA-Seq Reveals Deranged Developmental Hierarchy with Coexisting Oncogenic States and Immune Evasion Programs in ETP T-ALL
  Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Enhancer Rewiring Dependent Switch from BCL2 to MCL1 Dependency Predicts NOTCH1 Inhibition Response in T-ALL
  Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Determining Resistance Mechanisms in BRAF-mutated Multiple Myeloma
  Birgit Knoechel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all